Christy Riddle
Psychiatric/Mental Health · Evansville, INNPI 1790918951
Payments from drug & device makers
Across 336 payments — averaging $15.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$834
- Otsuka America Pharmaceutical, Inc.$829
- Supernus Pharmaceuticals, Inc.$510
- Teva Pharmaceuticals USA, Inc.$453
- Indivior Inc.$264
- Johnson & Johnson$257
- plus $2K from 18 others
What the payments were for
- Food & beverage$5,08899%
- Education$751%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 60 | $834 |
| Otsuka America Pharmaceutical, Inc. | 66 | $829 |
| Supernus Pharmaceuticals, Inc. | 22 | $510 |
| Teva Pharmaceuticals USA, Inc. | 28 | $453 |
| Indivior Inc. | 15 | $264 |
| Johnson & Johnson | 17 | $257 |
| Neurocrine Biosciences, Inc. | 14 | $250 |
| Corium, LLC | 20 | $247 |
| Ironshore Pharmaceuticals Inc. | 13 | $206 |
| Vanda Pharmaceuticals Inc. | 15 | $195 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 11 | $178 |
| Collegium Pharmaceutical, Inc. | 13 | $159 |
| Axsome Therapeutics, Inc. | 7 | $150 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $131 |
| Lundbeck LLC | 8 | $131 |
| AbbVie | 2 | $73 |
| E.r. Squibb & Sons, L.L.C. | 4 | $73 |
| Tris Pharma Inc | 3 | $54 |
| Braeburn Inc. | 2 | $41 |
| Avanir Pharmaceuticals, Inc. | 2 | $38 |
| Sunovion Pharmaceuticals Inc. | 3 | $33 |
| Biogen | 1 | $27 |
| Ultragenyx Pharmaceutical Inc. | 1 | $19 |
| Vertical Pharmaceuticals, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,162 in reported general payments places this provider in the 90th percentile of 729 psychiatric/mental health providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 22 | $182,131 |
| Abilify AsimtufiiAripiprazole | 12 | $66,570 |
| AuvelityDextromethorphan Hbr/Bupropion | 53 | $57,254 |
| RexultiBrexpiprazole | 33 | $50,270 |
| Invega SustennaPaliperidone Palmitate | 16 | $34,658 |
| Abilify MaintenaAripiprazole | 11 | $28,032 |
| FanaptIloperidone | 11 | $14,058 |
| Lurasidone Hcl | 35 | $10,729 |
| TrintellixVortioxetine Hydrobromide | 12 | $7,309 |
| Clomipramine Hcl | 15 | $5,343 |
| Trazodone Hcl | 134 | $4,466 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 34 | $4,342 |
| Clozapine | 65 | $4,147 |
| Buspirone Hcl | 164 | $3,894 |
| Aripiprazole | 90 | $3,275 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $250 | $182,13122 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Asimtufii, Rexulti, Abilify Maintena | $829 | $144,87256 claims |
| Axsome Therapeutics, Inc.Auvelity | $150 | $57,25453 claims |
| Johnson & JohnsonInvega Sustenna | $257 | $34,65816 claims |
| Vanda Pharmaceuticals Inc.Fanapt | $195 | $14,05811 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $131 | $7,30912 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 729 psychiatric/mental health providers in Indiana.
Other psychiatric/mental health in Evansville
- John WathenEvansville$19K
- Melinda HaltermanEvansville$10K
- Stephanie CarsonEvansville$9K
- Brooke KempfTerre Haute$1.1M
- Gerald LewisMerrillville$336K
- Lauren LutzColumbus$320K
- Sonya RuedlingerIndianapolis$134K
- Trina GreenwaldMarion$107K
- Paul DuncanJeffersonville$46K
- Morgan StamperConnersville$42K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.